Accretion Nutrav

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1KVQ01019
  • NSEID:
  • BSEID: 544694
INR
299.00
0.00 (0.00%)
BSENSE

Aug 10

BSE+NSE Vol: 2000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 110.00% vs NA in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 85.14% vs NA in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 50.52% vs NA in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 102.66% vs NA in Mar 2025

Compare Profit and Loss Results of Accretion Nutrav
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
33.00
473.00
-440.00
-93.02%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
33.00
473.00
-440.00
-93.02%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-10.00
10.00
100.00%
Raw Materials Consumed
25.00
472.00
-447.00
-94.70%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
0.00
1.00
0%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
3.00
-3.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
26.00
471.00
-445.00
-94.48%
Operating Profit (PBDIT) excl Other Income
6.00
2.00
4.00
200.00%
Other Income
0.00
9.00
-9.00
-100.00%
Operating Profit (PBDIT)
7.00
12.00
-5.00
-41.67%
Interest
0.00
4.00
-4.00
-100.00%
Profit before Depriciation and Tax
6.00
8.00
-2.00
-25.00%
Depreciation
0.00
1.00
-1.00
-100.00%
Profit Before Taxation & Exceptional Items
6.00
6.00
0.00
0.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
6.00
0.00
0.00%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
5.00
4.00
1.00
25.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3.00
53.00
-50.00
-94.34%
Profit Available for appropriations
8.00
57.00
-49.00
-85.96%
Appropriations
8.00
57.00
-49.00
-85.96%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
9.35
1.42
7.93
558.45%
Profit And Loss - Net Sales
Net Sales 33.60 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 110.00% vs NA in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.89 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 85.14% vs NA in Mar 2025

Profit And Loss - Interest
Interest 0.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 50.52% vs NA in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 5.07 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 102.66% vs NA in Mar 2025